Lundbeck Is Said to Express Interest in Buying Xeris Biopharma
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
Read the full story at Bloomberg Markets ↗
ImpactNotable 35/100
Why it mattersRule-based estimate: no strong signals; trust 9/10.
RegionsGlobal
Published2 h ago (Tue, 29 Sep 2026 16:33:55 GMT)
RetrievedTue, 29 Sep 2026 17:00:56 GMT via rss
ClassifiedTue, 29 Sep 2026 17:01:08 GMT by heuristic
AuthorMichelle F. Davis, Vinicy Chan and Crystal Tse